1. Home
  2. CACI vs CORT Comparison

CACI vs CORT Comparison

Compare CACI & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CACI
  • CORT
  • Stock Information
  • Founded
  • CACI 1962
  • CORT 1998
  • Country
  • CACI United States
  • CORT United States
  • Employees
  • CACI N/A
  • CORT N/A
  • Industry
  • CACI EDP Services
  • CORT Biotechnology: Pharmaceutical Preparations
  • Sector
  • CACI Technology
  • CORT Health Care
  • Exchange
  • CACI Nasdaq
  • CORT Nasdaq
  • Market Cap
  • CACI 7.3B
  • CORT 7.1B
  • IPO Year
  • CACI 1979
  • CORT N/A
  • Fundamental
  • Price
  • CACI $476.73
  • CORT $73.36
  • Analyst Decision
  • CACI Buy
  • CORT Strong Buy
  • Analyst Count
  • CACI 13
  • CORT 4
  • Target Price
  • CACI $502.83
  • CORT $142.00
  • AVG Volume (30 Days)
  • CACI 370.7K
  • CORT 1.4M
  • Earning Date
  • CACI 04-23-2025
  • CORT 05-05-2025
  • Dividend Yield
  • CACI N/A
  • CORT N/A
  • EPS Growth
  • CACI 22.32
  • CORT 8.36
  • EPS
  • CACI 21.19
  • CORT 1.14
  • Revenue
  • CACI $8,361,975,000.00
  • CORT $685,446,000.00
  • Revenue This Year
  • CACI $14.65
  • CORT $35.85
  • Revenue Next Year
  • CACI $7.25
  • CORT $35.22
  • P/E Ratio
  • CACI $22.52
  • CORT $64.25
  • Revenue Growth
  • CACI 14.16
  • CORT 30.93
  • 52 Week Low
  • CACI $318.60
  • CORT $25.35
  • 52 Week High
  • CACI $588.26
  • CORT $117.33
  • Technical
  • Relative Strength Index (RSI)
  • CACI 70.26
  • CORT 55.18
  • Support Level
  • CACI $460.14
  • CORT $68.86
  • Resistance Level
  • CACI $483.10
  • CORT $73.36
  • Average True Range (ATR)
  • CACI 11.17
  • CORT 3.31
  • MACD
  • CACI -1.20
  • CORT -0.08
  • Stochastic Oscillator
  • CACI 84.46
  • CORT 75.62

About CACI CACI International Inc.

CACI International Inc is an information solutions and services provider, offering information solutions and services to its customers. The company's primary customers are agencies and departments of the U.S. government, which account for the vast majority of the firm's revenue. It provides information solutions and services supporting national security missions and government modernization for intelligence, defense, and federal civilian customers. Some of the services provided by the company are functional software development, data, and business analysis, IT operations support, naval architecture, and life cycle support intelligence among others. The company's operating segments are; Domestic operations and International operations. It derives key revenue from the Domestic segment.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.

Share on Social Networks: